Score Overview
Explore the 2021 public Archive ranking →
Where USANA Health Sciences Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- USNA
2007: 29.2% · 2021: 17.9% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 14.82 | — |
1 Year2025-09-26 | $ 28.53 | -48.05% |
5 Years2021-09-28 | $ 91.26 | -83.76% |
10 Years2016-09-28 | $ 68.61 | -78.40% |
20 Years2006-09-28 | $ 23.43 | -36.75% |
30 Years1996-09-27 | $ 3.09 | 379.02% |
All Time1996-07-25 | $ 2.63 | 464.57% |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 | All Time1996-07-25 |
|---|---|---|---|---|---|---|---|
| Price | $ 14.82 | $ 28.53 | $ 91.26 | $ 68.61 | $ 23.43 | $ 3.09 | $ 2.63 |
| Return | — | -48.05% | -83.76% | -78.40% | -36.75% | 379.02% | 464.57% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 913M | -$ 22M | |
| 2025 | $ 925M | $ 10M | $ 158M |
| 2024 | $ 854M | $ 42M | $ 181M |
| 2023 | $ 921M | $ 63M | $ 330M |
| 2022 | $ 998M | $ 69M | $ 288M |
| 2021 | $ 1.18B | $ 116M | $ 239M |
| 2020 | $ 1.13B | $ 124M | $ 312M |
| 2019 | $ 1.06B | $ 100M | $ 234M |
| 2018 | $ 1.18B | $ 126M | $ 277M |
| 2017 | $ 1.04B | $ 62M | $ 247M |
| 2016 | $ 1.00B | $ 100M | $ 175M |
| 2015 | $ 918M | $ 94M | $ 143M |
| 2014 | $ 790M | $ 76M | $ 111M |
| 2013 | $ 718M | $ 79M | $ 145M |
| 2012 | $ 648M | $ 66M | $ 70M |
| 2011 | $ 581M | $ 50M | $ 50M |
| 2010 | $ 517M | $ 45M | $ 24M |
| 2009 | $ 436M | $ 33M | $ 13M |
| 2008 | $ 429M | $ 29M | $ 13M |
| 2007 | $ 423M | $ 45M | $ 12M |
| 2006 | $ 374M | $ 41M | $ 27M |
| 2005 | $ 327M | $ 38M | $ 10M |
| 2004 | $ 272M | $ 30M | $ 15M |
| 2003 | $ 200M | $ 20M | $ 18M |
| 2002 | $ 133M | $ 8M | $ 6M |
| 2001 | $ 114M | $ 2M | $ 2M |
| 2000 | $ 123M | $ 2M | $ 2M |
| 1999 | $ 129M | $ 5M | $ 1M |
| 1998 | $ 121M | $ 9M | $ 2M |
| 1997 | $ 85M | $ 6M | $ 2M |
| IPO1996 | $ 56M | $ 5M | $ 1M |
USANA Health Sciences Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 327M to $ 925M and net income declined from $ 38M to $ 10M. Revenue increased in 15 of those 20 years; net income in 10.
Across USANA Health Sciences Inc's full reported history, from 1996 to 2025, revenue grew from $ 56M to $ 925M and net income grew from $ 5M to $ 10M. Revenue increased in 77% of the years measured; net income in 57%.
USANA Health Sciences Inc currently holds a 20-year HDB Score of 3.7 out of 10. How the HDB Score is calculated.
Membership
Continue USNA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
